Michael F. Berger

Michael F. Berger's AcademicInfluence.com Rankings

Michael F. Berger

Philosophy

#11746

World Rank

#16231

Historical Rank

Logic

#8550

World Rank

#10716

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Michael F. Berger's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Michael F. Berger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael F. Berger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Smoking Is Associated With Progression of Diabetic Nephropathy (1994) (306)
Effect of age on excess mortality in obesity. (1999) (293)
Evaluation of an intensified insulin treatment and teaching programme as routine management of Type 1 (insulin-dependent) diabetes (1987) (214)
Validation of a Diabetes-Specific Quality-of-Life Scale for Patients With Type 1 Diabetes (1998) (209)
Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months (1983) (194)
Incidence of Lower Limb Amputations and Diabetes (1996) (192)
Assessment of excess mortality in obesity. (1998) (171)
Prevalence of renal artery stenosis in diabetes mellitus — an autopsy study (1991) (157)
Unchanged incidence of lower-limb amputations in a German City, 1990-1998. (2001) (152)
Patient education as the basis for diabetes care in clinical practice and research (1985) (151)
EVALUATION OF A STRUCTURED TREATMENT AND TEACHING PROGRAMME ON NON-INSULIN-DEPENDENT DIABETES (1988) (150)
Cigarette Smoking and Progression of Retinopathy and Nephropathy in Type 1 Diabetes (1996) (131)
Incidence and Management of Severe Hypoglycemia in 434 Adults with Insulin-dependent Diabetes Mellitus (1985) (115)
Predictors of Glycaemic Control in Type 1 Diabetic Patients after Participation in an Intensified Treatment and Teaching Programme (1994) (112)
Patient education – evaluation of a complex intervention (2002) (102)
Severe Hypoglycemia Incidence and Predisposing Factors in 85 Pregnancies of Type I Diabetic Women (1992) (95)
Evaluation of a structured treatment and teaching programme on hypertension in general practice. (1993) (90)
Prolonged QT interval as a predictor of mortality in diabetic nephropathy (1996) (90)
Evaluation of a structured treatment and teaching programme on asthma (1991) (90)
Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type I (insulin-dependent) diabetes (1986) (84)
Evidence‐based patient information in diabetes (2000) (82)
Social status and the quality of care for adult people with Type I (insulin-dependent) diabetes mellitus – a population-based study (1998) (78)
Cost-effectiveness of a structured treatment and teaching programme on asthma. (1993) (74)
Severe Hypoglycemia in Type I Diabetic Patients With Impaired Kidney Function (1991) (71)
Diabetes care and patient-oriented outcomes. (1999) (69)
Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy (1995) (62)
Implementation of Intensified Insulin Therapy: a European Perspective (1995) (61)
Pharmacokinetics and Bioavailability of Injected Glucagon: Differences Between Intramuscular, Subcutaneous, and Intravenous Administration (1985) (61)
Blindness Due to Diabetes: Population‐based Age‐ and Sex‐specific Incidence Rates (1997) (60)
Diabetes education and insulin therapy: when will they ever learn? (1993) (57)
Incidence of blindness in southern Germany between 1990 and 1998 (2001) (55)
Hypoglycemic Symptoms and Frequency of Severe Hypoglycemia in Patients Treated With Human and Animal Insulin Preparations (1991) (52)
Amputations and diabetes: a case‐control study (2002) (49)
Behaviour therapy versus doctor's anti‐smoking advice in diabetic patients (1993) (49)
Reliability of causes of death in persons with Type I diabetes (2002) (49)
Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. (1999) (45)
Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy (1996) (44)
Body weight, blood pressure, and mortality in a cohort of obese patients. (2002) (43)
Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for Type 1 (insulin-dependent) diabetes mellitus in Moscow—blood glucose versus urine glucose self-monitoring (1994) (42)
Uncontrolled Hypertension in Type 1 Diabetes: Assessment of Patients' Desires about Treatment and Improvement of Blood Pressure Control by a Structured Treatment and Teaching Programme (1988) (34)
Comparison of Methods for Determination of Microalbuminuria in Diabetic Patients (1989) (34)
Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes. (1999) (33)
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma (1992) (32)
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy (1996) (31)
Assessment of effort in clinical testing of cognitive functioning for adults (2009) (31)
Mechanism of Exercise-Induced Hypoglycemia During Sulfonylurea Treatment (1987) (30)
Improvement of hypertension care by a structured treatment and teaching programme. (1993) (29)
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy (2000) (28)
Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease (1997) (27)
Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance. (1992) (24)
HYPOGLYCAEMIC UNAWARENESS AND HUMAN INSULIN (1989) (24)
Measuring progression of diabetic nephropathy (1994) (24)
Atrial natriuretic factor in various stages of diabetic nephropathy. (1988) (23)
Mortality and Morbidity in Treated Hypertensive Type 2 Diabetic Patients with Micro‐ or Macroproteinuria (1995) (23)
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (2000) (22)
Clinical research under threat (2002) (16)
Insulin sensitivity in patients with essential hypertension: no influence of the ACE inhibitor enalapril. (1999) (16)
Miscibility of human and bovine ultralente insulin with soluble insulin. (1984) (13)
Effects of on‐demand β2‐agonist inhalation in moderate‐to‐severe asthma. A randomized controlled trial (2000) (13)
Non‐linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy (2000) (12)
Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy. (1990) (12)
Renal protective effect of enalapril in diabetic nephropathy. (1992) (11)
Quality assessment of diabetes care according to the recommendations of the St. Vincent Declaration: A population-based study in a rural area of Austria (1992) (10)
Chronically diseased patients and their doctors (2002) (10)
Diabetes as a predictor of mortality in a cohort of blind subjects. (1996) (10)
The Cochrane collaboration and its possible impact on diabetes care. (2000) (9)
Evaluation of a teaching and treatment programme for type I diabetic patients. (1984) (9)
Effects of intensification of antihypertensive care in diabetic nephropathy. (1995) (9)
Leucocyte count, proteinuria and smoking in type 1 diabetes mellitus (2004) (9)
Risk of obesity in type II diabetes mellitus. (1992) (8)
[Quality control of the self-measurement of blood sugar in unselected type I diabetics. The importance of patient training]. (2008) (8)
Prognosis and treatment of cardiovascular disease in Diabetes mellitus (1999) (7)
[Evidence-based medicine. Medicine based on rational principles]. (1997) (7)
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate) (2000) (6)
Antihypertensive treatment and mortality in diabetic patients What is the evidence? (1997) (6)
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate) [corrected]. (2000) (6)
Accuracy of blood glucose self monitoring in elderly insulin treated diabetic patients. (1991) (6)
Captopril, blood pressure, and diabetic nephropathy. (1994) (5)
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? (2004) (5)
Evaluation of a postgraduate course for diabetes educators. (1984) (5)
Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease (1998) (5)
Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy. (1996) (4)
[Amputations and mortality in elderly insulin-treated patients with type 2 diabetes]. (1999) (4)
[Perspectives and limits in treatment of obesity]. (2000) (4)
[Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies]. (1993) (4)
Metabolic effects of antihypertensive treatment with beta-blockers. (1991) (4)
Effects of antihypertensive treatment with beta-blockers on glucose metabolism. (1992) (3)
Effects of Antihypertensive Treatment with β‐Blockers on Glucose Metabolism (1992) (3)
[Nephropathy in type-1 diabetes]. (1993) (3)
For debate Patient education - evaluation of a complex intervention (2002) (3)
[The value of education of diabetics in the therapy of type 1 diabetes]. (1983) (3)
Non-Evidence-Based Concepts Are Still Established in the Treatment of IDDM (1998) (2)
Effect of 4-hour hyperglycaemia and hyperinsulinaemia on plasma atrial natriuretic factor concentrations. (1995) (2)
The cholesterol non-consensus. Methodological difficulties in the interpretation of epidemiological studies. (1992) (2)
Disease risks of obesity (1995) (2)
[Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy]. (1988) (2)
[Knowledge about technics of blood pressure determination of medical students in their internship year at the University of Düsseldorf]. (1988) (2)
The clinical significance of insulin resistance in the treatment of hypertension. (1994) (2)
Endless Debate About An Unsubstantiated Cause of Severe Hypoglycemia: Reply to Human Versus Porcine Insulin Gone Wrong (1992) (2)
[The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?]. (2009) (2)
What are the Options for Oral Agent Treatment of Type 2 Diabetes (2008) (1)
[Evaluation of education of the diabetic. Quality control in diabetes therapy]. (1983) (1)
Response From Authors (1993) (0)
[Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy]. (1994) (0)
[Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy]. (1998) (0)
[Insulin--the cause of hypertension?]. (1992) (0)
[Length of stay and length of work incapacity in patients with Type I diabetes. Effects of a diabetes treatment and education program]. (1986) (0)
Value of PET in the Clinical Evaluation of Dementias (1987) (0)
[Observations on the treatment of ovarian insufficiency]. (1953) (0)
Beneficial effects of a hypertension and treatment programme in blind type I diabetic patients with overt nephropathy (1994) (0)
[Renoparenchymal hypertension]. (1989) (0)
The Role of Patient Education in the Treatment of Type I Diabetes mellitus (1984) (0)

This paper list is powered by the following services:

Michael F. Berger's Academic­Influence.com Rankings

Michael F. Berger's Degrees

Why Is Michael F. Berger Influential?

Michael F. Berger's Published Works

Published Works

Michael F. Berger's AcademicInfluence.com Rankings